MetLife (NYSE:MET - Get Free Report) posted its earnings results on Wednesday. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30), Zacks reports. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%. The firm's quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.28 earnings per share.
MetLife Stock Performance
NYSE:MET traded up $1.28 during mid-day trading on Tuesday, reaching $76.58. 2,070,528 shares of the stock were exchanged, compared to its average volume of 3,426,053. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife has a 1 year low of $65.21 and a 1 year high of $89.05. The stock has a market capitalization of $51.41 billion, a P/E ratio of 12.99, a P/E/G ratio of 0.67 and a beta of 0.85. The company has a 50 day simple moving average of $78.02 and a 200-day simple moving average of $78.92.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a yield of 3.0%. MetLife's dividend payout ratio (DPR) is currently 38.47%.
MetLife announced that its Board of Directors has authorized a stock repurchase program on Wednesday, April 30th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its shares are undervalued.
Analysts Set New Price Targets
Several research analysts have weighed in on MET shares. Wells Fargo & Company restated an "overweight" rating and set a $97.00 price objective (up previously from $94.00) on shares of MetLife in a report on Thursday, July 10th. Wall Street Zen lowered shares of MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Jefferies Financial Group lifted their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research note on Monday. JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Finally, Morgan Stanley restated an "overweight" rating and set a $98.00 target price (down previously from $99.00) on shares of MetLife in a report on Monday, July 14th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $96.00.
Read Our Latest Analysis on MetLife
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the company. Empowered Funds LLC grew its position in MetLife by 187.6% during the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider's stock valued at $2,680,000 after acquiring an additional 21,771 shares during the period. Caxton Associates LLP purchased a new position in MetLife in the first quarter valued at about $307,000. Finally, Brighton Jones LLC boosted its holdings in MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after purchasing an additional 351 shares during the last quarter. Hedge funds and other institutional investors own 94.99% of the company's stock.
MetLife Company Profile
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.